PRECISION THERAPY FOR EPILEPSY DUE TO KCNT1 MUTATIONS: AN ORDER-RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED CROSS-OVER TRIAL OF ORAL QUINIDINE